- Conditions
- High Grade Upper Tract Urothelial Carcinoma
- Interventions
- Carboplatin, Cisplatin, Doxorubicin, Gemcitabine, Methotrexate, Nephroureterectomy, Pegfilgrastim, Vinblastine
- Drug · Procedure
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2022
- U.S. locations
- 134
- States / cities
- Birmingham, Alabama • Aurora, Colorado • Colorado Springs, Colorado + 93 more
Source: ClinicalTrials.gov public record
Updated Jul 9, 2023 · Synced May 4, 2026, 12:15 PM EDT